RelayPro Thoracic Stent-Graft System
Bolton Medical, Inc. · Decision date Sep 10, 2025
What did the FDA decide?
FDA records P200045/S020 as a supplement to PMA P200045, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 10, 2025.
FDA approval order statement
removal of a coating to a delivery system component and an update to the in-process quality inspection of delivery system of the RelayPro Thoracic Stent-Graft System
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 10, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P200045/S020
- Regulatory pathway
- PMA supplement
- Applicant
- Bolton Medical, Inc.
- Product code
- MIH
- Decision code
- OK30
- Decision date
- Sep 10, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.
- Applicant
- Bolton Medical, Inc.
- Product code
- MIH
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P200045. Subsequent supplements may change the device or its indications.
FDA decision timeline
P200045 · Original PMA
RelayPro Thoracic Stent-Graft System
P200045/S016 · Related supplement
RelayPro Thoracic Stent-Graft System
P200045/S020 received
Application receipt date recorded by FDA.
P200045/S020 · FDA decision
30-Day Notice
P200045/S018 · Related supplement
RelayPro Thoracic Stent-Graft System
P200045/S022 · Related supplement
RelayPro Thoracic Stent-Graft System
P200045/S017 · Related supplement
RelayPro Thoracic Stent-Graft System
P200045/S024 · Related supplement
RelayPro Thoracic Stent-Graft System
P200045/S025 · Related supplement
RelayPro Thoracic Stent-Graft Delivery System
Timeline entries are records held by MedtechLedger for P200045. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200045
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Bolton Medical, Inc. | PMA approval | Aug 5, 2021 | FDA | |
RelayPro Thoracic Stent-Graft SystemP200045/S016 | Bolton Medical, Inc. | PMA supplement | Jul 22, 2025 | FDA |
RelayProP200045/S019 | Bolton Medical, Inc. | PMA supplement | Sep 3, 2025 | FDA |
RelayPro Thoracic Stent-Graft SystemP200045/S018 | Bolton Medical, Inc. | PMA supplement | Oct 7, 2025 | FDA |
RelayPro Thoracic Stent-Graft SystemP200045/S022 | Bolton Medical, Inc. | PMA supplement | Feb 19, 2026 | FDA |
RelayPro Thoracic Stent-Graft SystemP200045/S017 | Bolton Medical, Inc. | PMA supplement | Apr 13, 2026 | FDA |
RelayPro Thoracic Stent-Graft SystemP200045/S024 | Bolton Medical, Inc. | PMA supplement | Jun 18, 2026 | FDA |
RelayPro Thoracic Stent-Graft Delivery SystemP200045/S025 | Bolton Medical, Inc. | PMA supplement | Oct 28, 2026 | FDA |
Explore the linked device profile
Other records with product code MIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook, Inc. | PMA supplement | Sep 17, 2026 | FDA | |
| Cook, Inc. | PMA supplement | Aug 4, 2026 | FDA | |
| Cook Medical Incorporated | PMA supplement | Aug 4, 2026 | FDA | |
| William Cook Europe Aps | PMA supplement | Aug 4, 2026 | FDA | |
GORE EXCLUDER Conformable AAA EndoprosthesisP200030/S026 | W. L. Gore and Associates, Inc. | PMA supplement | Jul 29, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Bolton Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 799 International Pkwy., Sunrise, FL, 33325
Sources and methodology
- Original FDA record: P200045/S020
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





